Sotatercept Tied to Disease Modification in PAH
Data show sotatercept may deliver significant clinical benefits and could reshape the trajectory of this challenging disease.
Source: medscape.com
📰 Altavant Sciences News
Altavant Sciences News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Altavant Sciences. Real-time updates on events, politics, business and more.
Hypertension Market to Accelerate Positively, Estimates DelveInsight | Key Companies Active in the Market - Novartis, Bayer, Merck, Insmed, Acceleron, AbbVie, Alnylam, Apnimed, AstraZeneca, Gossamer Bio
/PRNewswire/ -- DelveInsights Hypertension Market Insights report includes a comprehensive understanding of current treatment practices, hypertension emerging...
Source: prnewswire.com
Global Respiratory Disease Partnering Analysis Report 2023: Headline, Upfront, Milestone and Royalty Data for 1,000+ Deals
/PRNewswire/ -- The "Global Respiratory Partnering 2010-2023: Deal Trends, Players and Financials" report has been added to ResearchAndMarkets.coms offering....
United States United Kingdom Laura Wood Drug Administration Amyndas Pharmaceuticals E St Office Hours Call
Source: prnewswire.com
Global Respiratory Disease Partnering Analysis Report 2023:
Dublin, June 01, 2023 (GLOBE NEWSWIRE) -- The "Global Respiratory Partnering 2010-2023: Deal Trends, Players and Financials" report has been added to ...
United States United Kingdom Medidata Solutions Health Care Glenmark Pharmaceuticals Melinda Gates Foundation
Source: globenewswire.com
Roivant Sciences founder Ramaswamy considering 2024 presidential run - POLITICO (ROIV)
Vivek Ramaswamy, the founder and former CEO of Roivant Sciences (ROIV), is considering a bid for the Republican presidential nomination, POLITICO reported.
Source: seekingalpha.com
Global Respiratory Disease Partnering Report and Directory 2022: Company A-Z, Stage of Development at Signing, Deal Type (Collaborative R&D, Co-promotion, Licensing) and Technology Type
/PRNewswire/ -- The "Global Respiratory Partnering 2010-2022: Deal Trends, Players and Financials" report has been added to ResearchAndMarkets.coms offering....
United States United Kingdom Laura Wood Melinda Gates Foundation Innovative Medicines Initiative Alnylam Pharmaceuticals
Source: prnewswire.com
Enzyvant Stages NC HQ for Rare-Disease Battles | North Carolina Biotechnology Center
Enzyvant and Altavant, wholly owned subsidiaries of Sumitovant Biopharma, are forming a Triangle-based rare-disease biopha company.
Source: ncbiotech.org
Pulmonary Hypertension Clinical Trials Pipeline Offers Promising Novel Treatment Options | DelveInsight
DelveInsight’s pulmonary hypertension pipeline report depicts a robust space with 80+ active players working to develop...
Source: sina.com.hk
Worldwide Genitourinary Partnering Industry 2022 Report - Featuring 3SBio, 4D Science, 180 Medical, A1M Pharma and Many More
/PRNewswire/ -- The "Global Genitourinary Partnering 2010-2022: Deal Trends, Players and Financials" report has been added to ResearchAndMarkets.coms offering....
Source: prnewswire.com
The Lung Transplant Foundation to Host Externally-Led Patient-Focused Drug Development Meeting to Help Educate FDA on Living with Bronchiolitis Obliterans Syndrome (BOS)
/PRNewswire/ -- The Lung Transplant Foundation (LTF), a non-profit organization dedicated to creating a world where all lung transplant patients live long,...
Lindsay Rocco John Michael Reynolds Amy Skiba Zambon United States Ltd Mallinckrodt Pharmaceuticals Organization Contact
Source: prnewswire.com